Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 21,809,755
- Share change
- +19,125,037
- Total reported value
- $677,010,000
- Price per share
- $31.14
- Number of holders
- 40
- Value change
- +$593,409,007
- Number of buys
- 38
Report period
Q4 2019
Institutions
40
Top holders
10
PHAT full security history
Newer quarter: Q1 2020
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q4 2019
As of 31 Dec 2019,
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,809,755 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Invesco Ltd., Medicxi Ventures Management (Jersey) Ltd, JANUS HENDERSON GROUP PLC, Abingworth LLP, BVF INC/IL, BlackRock Inc., Ensign Peak Advisors, Inc, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q4 2025 Across Filers
Q4 2025 holders
173
Q4 2019 holders
40
Holder diff
-133
| Investor | Q4 2025 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.